INS and diabetes mellitus: Hence, key players of the diabetes- breast cancer crosstalk include insulin and its binding to insulin receptor which triggers the insulin pathway, and which subsequently leads to the activation of PI3K-AKT and MAPK pathways, and HIF1 signaling via mTOR pathway [124].